Evidence map›Paper›PMID 32811974›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2020

Cost-effectiveness of probiotics for necrotizing enterocolitis prevention in very low birth weight infants.

Atoosa F Craighead, Aaron B Caughey, Anoshua Chaudhuri, Leah Yieh, Alyssa R Hersh, Dmitry Dukhovny

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Quality, outcome, and cost of care provided to very low birth weight infants in California.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  3. Article
  4. Probiotics in the Prevention and Treatment of Necrotizing Enterocolitis.Pediatric gastroenterology, hepatology & nutrition · 2021
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Atoosa F CraigheadDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA. AtoosaFCraighead@gmail.com.
Aaron B CaugheyDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
Anoshua ChaudhuriDepartment of Economics, San Francisco State University, San Francisco, CA, USA.
Leah YiehFetal and Neonatal Institute, Division of Neonatology, Children's Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-6640-971X
Alyssa R HershDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
Dmitry DukhovnyDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
Oregon Health & Science University · USSan Francisco State University · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the cost-effectiveness of prophylactic probiotics on necrotizing enterocolitis (NEC) prevention in very low birth weight (VLBW) infants. STUDY

designWe built a decision-analytic model using TreeAge. Effectiveness was assessed using quality-adjusted life-years (QALY). Primary outcome was an incremental cost-effectiveness ratio (ICER) expressed as cost per QALY gained. Costs were expressed in 2017 US dollars. Deterministic and probabilistic sensitivity analyses (SA) were performed.

resultsFor the base case analysis, the ICER of probiotics versus no probiotics for the prevention of NEC in VLBW infants was $1868/QALY. SA revealed that probiotics became cost-saving at a NEC rate of 6.5% and higher or with incremental NEC cost of $37,500 or higher.

conclusionsOur model demonstrated that prophylactic probiotics were a cost-effective strategy in NEC reduction. SA confirmed that the model is customizable to various clinical settings and thus, can aid in understanding the economic impact of this intervention.

Indexed as

Enterocolitis, NecrotizingProbioticsCost-Benefit AnalysisDecision TreesHumansInfantInfant, NewbornInfant, PrematureInfant, Very Low Birth Weight

Identifiers

PMID32811974
OpenAlexW3073636905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.